Title:
APPLICATION OF TRANILAST IN PREPARATION OF DRUG TREATING SCLEREDEMA DIABETICORUM
Document Type and Number:
WIPO Patent Application WO/2017/118446
Kind Code:
A2
Abstract:
Disclosed is an application of tranilast in the preparation of a drug treating scleredema diabeticorum. Tranilast has been used for many years in the clinical treatment of allergic diseases and keloids, and is a safe and effective drug with few adverse reactions. Now, tranilast is used for scleredema diabeticorum patients who have no clear clinical treatment program. After tranilast has been applied for three months, clinical observations show that symptoms are significantly eased, and B-scans detect that skin thickness is significantly thinner, without any significant adverse reactions. This indicates that the drug rapidly controls skin damage in scleredema diabeticorum patients, and reduces clinical symptoms of scleredema diabeticorum. Tolerance is good, patient compliance is high, adverse reactions are rare, and the clinical efficacy and safety of the drug are good.
Inventors:
HOU MAIHUA (CN)
LU XINZHENG (CN)
SUN MIN (CN)
YANG FENG (CN)
LU XINZHENG (CN)
SUN MIN (CN)
YANG FENG (CN)
Application Number:
PCT/CN2017/075507
Publication Date:
July 13, 2017
Filing Date:
March 03, 2017
Export Citation:
Assignee:
FIRST AFFILIATED HOSPITAL NANJING MEDICAL UNIV (CN)
International Classes:
A61K31/196; A61P17/00
Attorney, Agent or Firm:
NANJING ZHISHI LAW FIRM OF INTELLECTUAL PROPERTY (CN)
Download PDF:
Previous Patent: COMPOSITE FILTER CARTRIDGE
Next Patent: A PREPARATION METHOD OF AMORPHOUS APREMILAST
Next Patent: A PREPARATION METHOD OF AMORPHOUS APREMILAST